GenEp Bio Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
- Investors
-
1
GenEp Bio General Information
Description
Operator of a biotechnological company intended to create therapies targeting mutations of sodium and other ion channels. The company specializes in selective compounds that modulate sodium channels that result in treatment resistance in certain rare genetic epilepsies, enabling medical professionals to develop effective therapies for these patients' medical needs.
Contact Information
Website
www.genepbio.comCorporate Office
- 310 2nd Street SouthEast
- Suite B
- Charlottesville, VA 22902
- United States
Corporate Office
- 310 2nd Street SouthEast
- Suite B
- Charlottesville, VA 22902
- United States
GenEp Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 26-Apr-2026 | Completed | Out of Business | |||
| 4. Early Stage VC (Series 3) | 10-Sep-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 24-Oct-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 13-Sep-2021 | Completed | Generating Revenue |
GenEp Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 195,772 | $0.000100 | 8% | $16.09 | $16.09 | 1x | $16.09 | 9.49% |
GenEp Bio Patents
GenEp Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025231324-A1 | Imidazole compounds and their use as sodium channel inhibitors | Pending | 02-May-2024 | ||
| WO-2025122832-A1 | Imidazole compounds and their use as sodium channel inhibitors | Inactive | 07-Dec-2023 | ||
| WO-2025122845-A1 | Imidazole compounds and their use as sodium channel inhibitors | Inactive | 07-Dec-2023 | ||
| AU-2023374468-A1 | Imidazole compounds and their use as sodium channel inhibitors | Pending | 31-Oct-2022 | ||
| EP-4611747-A1 | Imidazole compounds and their use as sodium channel inhibitors | Pending | 31-Oct-2022 | C07D233/64 |
GenEp Bio Signals
GenEp Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| University of Virginia | University |
GenEp Bio FAQs
-
When was GenEp Bio founded?
GenEp Bio was founded in 2021.
-
Where is GenEp Bio headquartered?
GenEp Bio is headquartered in Charlottesville, VA.
-
What is the size of GenEp Bio?
GenEp Bio has 2 total employees.
-
What industry is GenEp Bio in?
GenEp Bio’s primary industry is Biotechnology.
-
Is GenEp Bio a private or public company?
GenEp Bio is a Private company.
-
What is GenEp Bio’s current revenue?
The current revenue for GenEp Bio is .
-
How much funding has GenEp Bio raised over time?
GenEp Bio has raised $8.96M.
-
Who are GenEp Bio’s investors?
University of Virginia has invested in GenEp Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process